IndiaOne Finance - Company Dashboard

Governance Classic Home

Auro Laboratories LtdPharmaceuticalsINE292C01011

Valuation

Market Cap₹155.87 Cr

TTM PE33.26x

Forward PE29.45x

PEG1.16

Book Value₹1042.08

P/B0.24x

TTM EPS₹7.52

Fwd EPS₹8.49

TTM Revenue₹36.83 Cr

TTM PAT₹4.69 Cr

TTM EBITDA₹13.04 Cr

TTM EBIT₹9.60 Cr

Last Qtr PAT₹0.97 Cr

Last Qtr EBITDA₹3.30 Cr

Last Qtr EBIT₹2.39 Cr

Profitability

ROE—

ROCE—

TTM NPM12.73%

TTM EBITDA %35.41%

Curr OPM11.93%

Last OPM9.86%

Curr NPM—

Last NPM—

Curr EPS₹1.68

Last EPS₹1.56

Balance sheet

Equity—

Reserve—

Total Debt₹0.00 Cr

D/E—

Interest %130.48%

Curr Interest₹1.37 Cr

Price / range

Close₹250.10

vs 52W High-21.10%

vs 52W Low+57.30%

MA50—

MA200—

Returns

1D+0.08%

1W-1.46%

1M+6.20%

3M-0.58%

6M-10.36%

1Y+4.45%

2Y+30.23%

3Y+116.35%

5Y+106.27%

Diwali+2.61%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1868.90	₹4.48L Cr	150.72	3.58%
DIVISLAB	9410.50	₹2.50L Cr	84.94	17.55%
TORNTPHARM	4970.00	₹1.89L Cr	80.92	25.43%
ZYDUSLIFE	1161.00	₹1.16L Cr	33.24	12.96%
CIPLA	1386.10	₹1.12L Cr	36.42	8.93%
LAURUSLABS	2017.50	₹1.09L Cr	124.85	16.46%
MANKIND	2437.80	₹1.01L Cr	46.14	13.38%
DRREDDY	1198.30	₹1.00L Cr	150.35	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	8.77+216.6%	9.83	9.39	8.84	2.77	30.74
Other Income	0.11	0.66	0.18	0.98	0.42	2.01
Total Income	8.88+178.4%	10.50	9.57	9.81	3.19	32.75
Interest	1.37	1.49	1.52	0.96	0.28	4.25
Expenditure	-7.75-142.2%	-8.90	-7.83	-8.09	-3.20	-27.80
PBDT	0	0	0	0	0	0
EBITDA	3.30+2650.0%	3.32	4.06	2.36	0.12	10
Depreciation	-0.91	-0.90	-0.98	-0.65	-0.27	-2.81
EBIT	2.39+1693.3%	2.42	3.08	1.71	-0.15	7.19
PBT	1.13	1.46	1.74	1.72	0	4.81
Tax	-0.09	-0.49	0.21	-1	0	-1.28
Equity	0	0	0	0	0	0
OPM	12.90	14.80	18.50	19.46	0.00	15.00
Net Profit	1.05+1054.5%	0.97	1.95	0.72	-0.11	3.53
NPM	11.93	9.86	20.78	8.10	-3.79	11.00
EPS	1.68	1.56	3.13	1.15	0	5.67

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	30.74+58.5%	19.40-63.8%	53.64+1.4%	52.89+4.0%	50.87-6.2%	54.25
Other Income	2.01	0.66	1.50	0.94	1.09	0.76
Total Income	32.75+63.3%	20.05-63.6%	55.14+2.4%	53.84+3.6%	51.96-5.5%	55.01
Expenditure	-27.80-53.6%	-18.10+59.6%	-44.79+11.1%	-50.39-4.8%	-48.08-8.0%	-44.50
Interest	-4.25	-1.08	-0.74	-0.81	-0.83	-0.46
PBDT	0	0	0	0	0	0
EBITDA	10+187.4%	3.48-67.4%	10.68+143.8%	4.38-5.6%	4.64-58.8%	11.25
Depreciation	-2.81	-1.10	-1.09	-1.07	-1.02	-1.04
EBIT	7.19+202.1%	2.38-75.2%	9.59+189.7%	3.31-8.6%	3.62-64.5%	10.21
PBT	4.81+155.9%	1.88-81.8%	10.35+200.0%	3.45-10.9%	3.87-63.2%	10.51
Tax	-1.28	0	-2.55	-1	-1.03	-3.33
Equity	0	0	0	0	0	0
OPM (%)	15.00	9.00	19.00	6.00	7.00	19.00
Net Profit	3.53+91.8%	1.84-76.4%	7.79+219.3%	2.44-14.4%	2.85-60.3%	7.18
NPM (%)	11.00	9.00	14.00	5.00	5.00	13.00
EPS (Rs)	5.67+92.2%	2.95-76.4%	12.50+218.9%	3.92-14.0%	4.56-60.4%	11.52
CEPS	5.67	2.95	12.50	3.92	4.56	11.52

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split